Glenmark Life Sciences IPO subscription to start from 27 July 2021, Tuesday. The retail portion of this IPO is 35%, QIB is 50% and HNI is 15% quota. The company removed the share holders quota from RHP and it might be worry for the retail investors. The investors will surely look at the company financials and the demand and looks on a good side. The Glenmark Life Sciences price band is fixed at ₹695 to ₹720 Per Share with face value of ₹2 Per Equity Share. The minimum bid is for 20 Shares (₹14,400) and maximum bid is 260 shares (187,200). Glenmark Life Sciences IPO to raise ₹1514 Crores via initial public offer. Please check the Glenmark Life Sciences IPO
details over here.
We recommend investors to apply this IPO with short term and long term gain. The IPO Subscription started!
The Glenmark Life Sciences IPO subscribed 44.17x on day 3 till 5:00 PM. The subscription comprises QIB 36.97x, NII 122.54x and RII 14.63x.